Literature DB >> 15838243

Inflammation and tissue damage in crystal deposition diseases.

Nicola Dalbeth1, Dorian O Haskard.   

Abstract

PURPOSE OF REVIEW: The crystal-induced arthropathies are characterized by self-limiting episodes of acute inflammation and chronic tissue damage. This review summarizes recent advances in the understanding of the cellular responses to monosodium urate, calcium pyrophosphate dihydrate and basic calcium phosphate crystals. RECENT
FINDINGS: Factors such as the myeloid related proteins, endothelin-1 and the complement membrane attack complex have been recently identified as mediators of acute crystal-induced inflammation. In addition, signalling pathways involved in both acute inflammation and tissue damage in crystal arthropathies have been further clarified. The potential of macrophage-derived transforming growth factor beta1 to play a key role in the resolution phase of acute gout has also been demonstrated.
SUMMARY: Recent work has provided new insights into the regulation of both acute and chronic articular responses to inflammatory microcrystals. Further analysis of these responses may identify potential therapeutic targets for management of the crystal-induced arthropathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838243     DOI: 10.1097/01.bor.0000157041.12116.69

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  10 in total

Review 1.  Ectosomes as modulators of inflammation and immunity.

Authors:  S Sadallah; C Eken; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

Review 2.  [Gouty arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

3.  Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?

Authors:  Matthew J Coleshill; Eindra Aung; Jane E Carland; Kate Faasse; Sophie Stocker; Richard O Day
Journal:  Ther Innov Regul Sci       Date:  2020-07-13       Impact factor: 1.778

4.  Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.

Authors:  Frank Haberman; Sung-Chun Tang; Thiruma V Arumugam; Dong-Hoon Hyun; Qian-Sheng Yu; Roy G Cutler; Zhihong Guo; Harold W Holloway; Nigel H Greig; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2007-08-10       Impact factor: 3.843

Review 5.  [Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

6.  Laser treatment of synovial inflammatory process in experimentally induced microcrystalline arthritis in Wistar rats.

Authors:  Débora Mara Fortes Bartoli; Airton Luiz Felizatti; Fernando Russo Costa do Bomfim; Julia Leme Bovo; Andrea Aparecida de Aro; Maria Esméria Corezzola do Amaral; Marcelo Augusto Marretto Esquisatto
Journal:  Lasers Med Sci       Date:  2020-06-10       Impact factor: 3.161

Review 7.  Gout--current diagnosis and treatment.

Authors:  Anne-Kathrin Tausche; Tim L Jansen; Hans-Egbert Schröder; Stefan R Bornstein; Martin Aringer; Ulf Müller-Ladner
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

8.  [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].

Authors:  N Announ; P-A Guerne
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

9.  Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.

Authors:  Anne-Kathrin Tausche; Carsten Wunderlich; Martin Aringer
Journal:  Case Rep Med       Date:  2011-05-14

Review 10.  Lesinurad: A significant advancement or just another addition to existing therapies of gout?

Authors:  Ajay Gupta; Pramod Kumar Sharma; Arup Kumar Misra; Surjit Singh
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.